Goldman Sachs lowered the firm’s price target on Houlihan Lokey (HLI) to $210 from $243 and keeps a Buy rating on the shares. Investment banking volumes are up 4% year over year through March 9, though growth has slowed recently and could turn negative if geopolitical uncertainty persists, a risk already reflected in bank stocks, which are down about 15% year to date and have underperformed the S&P 500 due to multiple compression, the analyst tells investors in a research note. Despite near-term volatility, longer-term prospects for M&A remain constructive, with the cycle viewed as still in its middle stages relative to the 2023 trough, the firm says.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLI:
- Houlihan Lokey Files Prospectus Supplement for Share Resales
- Houlihan Lokey Earnings Call Highlights Growth Momentum
- Houlihan Lokey price target raised to $196 from $193 at UBS
- Houlihan Lokey announces planned director board departure
- Houlihan Lokey price target lowered to $214 from $218 at Keefe Bruyette
